Li found that tanshinone IIA could inhibit the angiogenesis and growth of human breast cancer xenografts in nude mice and inhibit VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway. Here, RPS6 is linked to breast carcinoma.